Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Purchased by Northern Trust Corp

Northern Trust Corp lifted its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 20.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 891,112 shares of the company's stock after purchasing an additional 151,391 shares during the period. Northern Trust Corp owned 0.34% of Ryan Specialty worth $57,174,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the company. The Manufacturers Life Insurance Company lifted its holdings in shares of Ryan Specialty by 2.5% during the fourth quarter. The Manufacturers Life Insurance Company now owns 85,528 shares of the company's stock valued at $5,487,000 after purchasing an additional 2,119 shares during the last quarter. Aquatic Capital Management LLC boosted its stake in shares of Ryan Specialty by 7,434.4% in the 4th quarter. Aquatic Capital Management LLC now owns 45,357 shares of the company's stock worth $2,910,000 after buying an additional 44,755 shares during the last quarter. Susquehanna Fundamental Investments LLC bought a new stake in shares of Ryan Specialty during the 4th quarter valued at about $5,513,000. Nebula Research & Development LLC grew its position in shares of Ryan Specialty by 47.6% during the 4th quarter. Nebula Research & Development LLC now owns 27,576 shares of the company's stock valued at $1,769,000 after acquiring an additional 8,892 shares during the period. Finally, Voya Investment Management LLC increased its position in Ryan Specialty by 116.0% in the fourth quarter. Voya Investment Management LLC now owns 103,029 shares of the company's stock worth $6,610,000 after buying an additional 55,336 shares in the last quarter. 84.82% of the stock is owned by institutional investors.

Ryan Specialty Stock Down 1.9%

Shares of NYSE:RYAN traded down $1.32 on Monday, reaching $68.41. The company had a trading volume of 212,117 shares, compared to its average volume of 972,756. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. The firm has a market capitalization of $17.92 billion, a PE ratio of 98.84, a PEG ratio of 1.19 and a beta of 0.68. Ryan Specialty Holdings, Inc. has a 52-week low of $52.34 and a 52-week high of $77.16. The firm's 50 day simple moving average is $70.16 and its 200-day simple moving average is $68.73.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.39 EPS for the quarter, meeting the consensus estimate of $0.39. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The firm had revenue of $690.17 million during the quarter, compared to analyst estimates of $680.80 million. During the same quarter in the prior year, the business posted $0.35 EPS. The business's revenue for the quarter was up 25.0% compared to the same quarter last year. As a group, analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th will be paid a dividend of $0.12 per share. The ex-dividend date is Tuesday, May 13th. This represents a $0.48 annualized dividend and a yield of 0.70%. Ryan Specialty's payout ratio is presently 141.18%.

Insiders Place Their Bets

In related news, EVP Brendan Martin Mulshine sold 30,000 shares of the stock in a transaction on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 11.10% of the stock is currently owned by insiders.

Analysts Set New Price Targets

RYAN has been the subject of several research analyst reports. TD Cowen began coverage on Ryan Specialty in a research report on Thursday, April 10th. They set a "buy" rating and a $89.00 target price for the company. UBS Group lifted their target price on Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a report on Wednesday, February 26th. Keefe, Bruyette & Woods dropped their target price on Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a research report on Wednesday, April 9th. Barclays reduced their target price on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating on the stock in a research note on Friday, April 11th. Finally, Wells Fargo & Company lowered their target price on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a research note on Thursday, April 10th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $75.67.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.